Zobrazeno 1 - 10
of 166
pro vyhledávání: '"Gil I. Wolfe"'
Autor:
Patricia Sikorski, Yaoxiang Li, Mehar Cheema, Gil I. Wolfe, Linda L. Kusner, Inmaculada Aban, Henry J. Kaminski
Publikováno v:
PLoS ONE, Vol 18, Iss 10 (2023)
Externí odkaz:
https://doaj.org/article/b2233cf645124079b978488ad84c4b8a
Autor:
Ali G. Hamedani, Tarrant O. McPherson, Inmaculada Aban, Ikjae Lee, Mark J. Kupersmith, Gil I. Wolfe, Henry J. Kaminski
Publikováno v:
Journal of Clinical Neuromuscular Disease. 24:222-228
Autor:
Mamatha Pasnoor, Vera Bril, Todd Levine, Jaya Trivedi, Nicholas J. Silvestri, Milind Phadnis, Hans D. Katzberg, David S. Saperstein, Gil I. Wolfe, Laura Herbelin, Kiley Higgs, Andrew J. Heim, Jeffrey M. Statland, Richard J. Barohn, Mazen M. Dimachkie
Publikováno v:
European Journal of Neurology. 30:1417-1424
Autor:
Joel Oger, Joshua D Green, Bryan J Traynor, Richard J Barohn, Michael Benatar, Emanuela Bartoccion, Derrick Blackmore, Manisha Chopra, Andrea Corse, Mazen M Dimachkie, Amelia Evoli, Julaine Florence, Miriam Freimer, James F Howard, Theresa Jiwa, Henry J Kaminski, John T Kissel, Wilma J Koopman, Bernadette Lipscomb, Michelanglo Maestri, Mariapaola Marino, Janice M Massey, April McVey, Michelle M Mezei, Michael W Nicolle, Robert M Pascuzzi, Mamatha Pasnoor, Alan Pestronk, Carlo Provenzano, Roberta Ricciardi, David P Richman, Julie Rowin, Donald B Sanders, Zaeem Siddiqi, Aimee Soloway, Gil I Wolfe, Charlie Wulf, Daniel B Drachman
Publikováno v:
BMJ Open, Vol 10, Iss 9 (2020)
Objectives To approximate the rate of familial myasthenia gravis and the coexistence of other autoimmune disorders in the patients and their families.Design Retrospective cohort study.Setting Clinics across North America.Participants The study includ
Externí odkaz:
https://doaj.org/article/0145aad817a242af8725bc4e583792df
Autor:
Cleo-Aron Weis, Inmaculada B Aban, Garry Cutter, Henry J Kaminski, Christoph Scharff, Benedict W Grießmann, Maria Deligianni, Klaus Kayser, Gil I Wolfe, Philipp Ströbel, Alexander Marx
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0197435 (2018)
The thymectomy specimens from the "thymectomy trial in non-thymomatous myasthenia gravis patients receiving prednisone therapy" (MGTX) underwent rigid and comprehensive work-up, which permits analysis of the spatial distribution of histological and i
Externí odkaz:
https://doaj.org/article/4e7a2a7d5d2548e3b940221334b3b9f2
Autor:
Rodrigo Salinas, Carolina Vidal, Gil I. Wolfe, Gabriel Cea, Lorena Hoffmeister, Juan Pablo Contreras
Publikováno v:
Acta Neurologica Scandinavica. 144:546-552
OBJECTIVES The aim of this study was to achieve the translation and cross-cultural adaptation of the MG-QOL15R questionnaire into Spanish and the analysis of its psychometric properties. MATERIALS AND METHODS We recruited patients with MG, ≥18 year
Autor:
Gil I. Wolfe, David Lacomis
Publikováno v:
Journal of Clinical Neuromuscular Disease. 22:147-154
This update begins with myasthenia gravis and the roles of anti-agrin and cortactin antibodies. Regarding diagnosis, a report on repeated ice pack testing is highlighted as are several reports on the close correlation of electrodiagnostic testing wit
Autor:
Merit Cudkowicz, Richard J. Barohn, Gil I. Wolfe, NeuroNEXT Nn BeatMG Study Team, Brenda Pearson, Muhammad Al-Lozi, David P. Richman, David A. Hafler, Michael Benatar, Kevin C. O’Connor, Robin Conwit, A. Gordon Smith, Eroboghene E. Ubogu, Richard Nowak, Emma Ciafaloni, Liz Uribe, Jonathan Goldstein, Mazen M. Dimachkie, Miriam Freimer, Michael E. Shy, Anthony A. Amato, Sharon P. Nations, Aditi Sharma, Jon W. Yankey, Ted M. Burns, Christopher S. Coffey, Laura Ann Sams, John T. Kissel, Dianna Quan, Volkan Granit
Publikováno v:
Neurology
Neurology, vol 98, iss 4
Neurology, vol 98, iss 4
Background and ObjectiveTo determine whether rituximab is safe and potentially beneficial, warranting further investigation in an efficacy trial for acetylcholine receptor antibody-positive generalized myasthenia gravis (AChR-Ab+ gMG).MethodsThe B-Ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a034452bec80ce3be9a64cbbab0fdb1
https://europepmc.org/articles/PMC8793103/
https://europepmc.org/articles/PMC8793103/
Publikováno v:
RRNMF Neuromuscular Journal. 1:13-21
Coronavirus disease of 2019 (COVID-19) belongs to the betacoronavirus family which is known to cross species barriers and lead to high pathogenicity. There is rapidly growing evidence that COVID-19 infection can be associated with neuromuscular compl
Autor:
Petra W. Duda, Ikjae Lee, Gil I. Wolfe, Henry J. Kaminski, Tarrant McPherson, Ramin Farzaneh-Far, Inmaculada Aban, Gary Cutter
Publikováno v:
Muscle & Nerve
Introduction Quantitative Myasthenia Gravis (QMG) and Myasthenia Gravis Activities of Daily Living (MG‐ADL) scales were compared using the data from the Thymectomy Trial in Non‐Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy (